A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test

Chun Hsin Chen, Tsang Yaw Lin, Tzu Ting Chen, Vincent Chin Hung Chen, Ni Chi Lin, Wen Chuan Shao, Mong Liang Lu

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Increasing attention has been paid recently to the potential diabetogenic effect of second-generation antipsychotics (SGAs). The objective of this prospective study was to evaluate the effects of quetiapine treatment on pancreatic beta-cell function in SGA-naïve schizophrenic patients. Seventeen schizophrenic subjects completed an eight-week trial. The metabolic parameters were assessed at weeks 0, 2, 4, and 8. We measured glucose homeostasis with the intravenous glucose tolerance test. After the eight-week treatment, body weight and body mass index showed to be significantly increased compared to those at baseline. No significant changes were found in serum levels of fasting glucose, insulin, total cholesterol, and high-density lipoprotein. Insulin resistance and insulin secretion were significantly increased. Incidences of clinically significant weight gain and treatment-emergent metabolic syndrome were 11.8% and 11.8%, respectively. This study result confirms the association of quetiapine treatment and impairment of glucose homeostasis in schizophrenic patients.

Original languageEnglish
Pages (from-to)965-969
Number of pages5
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume35
Issue number4
DOIs
Publication statusPublished - Jun 1 2011

Fingerprint

Glucose Tolerance Test
Homeostasis
Prospective Studies
Glucose
Antipsychotic Agents
Insulin
Cohort Effect
Insulin-Secreting Cells
Therapeutics
HDL Cholesterol
Weight Gain
Insulin Resistance
Fasting
Body Mass Index
Body Weight
Quetiapine Fumarate
Incidence
Serum

Keywords

  • Insulin resistance
  • Insulin secretion
  • Metabolic syndrome
  • Quetiapine
  • Schizophrenia

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test. / Chen, Chun Hsin; Lin, Tsang Yaw; Chen, Tzu Ting; Chen, Vincent Chin Hung; Lin, Ni Chi; Shao, Wen Chuan; Lu, Mong Liang.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 35, No. 4, 01.06.2011, p. 965-969.

Research output: Contribution to journalArticle

@article{4d99200718db473aacc4d212052740f9,
title = "A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test",
abstract = "Increasing attention has been paid recently to the potential diabetogenic effect of second-generation antipsychotics (SGAs). The objective of this prospective study was to evaluate the effects of quetiapine treatment on pancreatic beta-cell function in SGA-na{\"i}ve schizophrenic patients. Seventeen schizophrenic subjects completed an eight-week trial. The metabolic parameters were assessed at weeks 0, 2, 4, and 8. We measured glucose homeostasis with the intravenous glucose tolerance test. After the eight-week treatment, body weight and body mass index showed to be significantly increased compared to those at baseline. No significant changes were found in serum levels of fasting glucose, insulin, total cholesterol, and high-density lipoprotein. Insulin resistance and insulin secretion were significantly increased. Incidences of clinically significant weight gain and treatment-emergent metabolic syndrome were 11.8{\%} and 11.8{\%}, respectively. This study result confirms the association of quetiapine treatment and impairment of glucose homeostasis in schizophrenic patients.",
keywords = "Insulin resistance, Insulin secretion, Metabolic syndrome, Quetiapine, Schizophrenia",
author = "Chen, {Chun Hsin} and Lin, {Tsang Yaw} and Chen, {Tzu Ting} and Chen, {Vincent Chin Hung} and Lin, {Ni Chi} and Shao, {Wen Chuan} and Lu, {Mong Liang}",
year = "2011",
month = "6",
day = "1",
doi = "10.1016/j.pnpbp.2011.01.015",
language = "English",
volume = "35",
pages = "965--969",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test

AU - Chen, Chun Hsin

AU - Lin, Tsang Yaw

AU - Chen, Tzu Ting

AU - Chen, Vincent Chin Hung

AU - Lin, Ni Chi

AU - Shao, Wen Chuan

AU - Lu, Mong Liang

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Increasing attention has been paid recently to the potential diabetogenic effect of second-generation antipsychotics (SGAs). The objective of this prospective study was to evaluate the effects of quetiapine treatment on pancreatic beta-cell function in SGA-naïve schizophrenic patients. Seventeen schizophrenic subjects completed an eight-week trial. The metabolic parameters were assessed at weeks 0, 2, 4, and 8. We measured glucose homeostasis with the intravenous glucose tolerance test. After the eight-week treatment, body weight and body mass index showed to be significantly increased compared to those at baseline. No significant changes were found in serum levels of fasting glucose, insulin, total cholesterol, and high-density lipoprotein. Insulin resistance and insulin secretion were significantly increased. Incidences of clinically significant weight gain and treatment-emergent metabolic syndrome were 11.8% and 11.8%, respectively. This study result confirms the association of quetiapine treatment and impairment of glucose homeostasis in schizophrenic patients.

AB - Increasing attention has been paid recently to the potential diabetogenic effect of second-generation antipsychotics (SGAs). The objective of this prospective study was to evaluate the effects of quetiapine treatment on pancreatic beta-cell function in SGA-naïve schizophrenic patients. Seventeen schizophrenic subjects completed an eight-week trial. The metabolic parameters were assessed at weeks 0, 2, 4, and 8. We measured glucose homeostasis with the intravenous glucose tolerance test. After the eight-week treatment, body weight and body mass index showed to be significantly increased compared to those at baseline. No significant changes were found in serum levels of fasting glucose, insulin, total cholesterol, and high-density lipoprotein. Insulin resistance and insulin secretion were significantly increased. Incidences of clinically significant weight gain and treatment-emergent metabolic syndrome were 11.8% and 11.8%, respectively. This study result confirms the association of quetiapine treatment and impairment of glucose homeostasis in schizophrenic patients.

KW - Insulin resistance

KW - Insulin secretion

KW - Metabolic syndrome

KW - Quetiapine

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=79956051087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956051087&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2011.01.015

DO - 10.1016/j.pnpbp.2011.01.015

M3 - Article

C2 - 21291941

AN - SCOPUS:79956051087

VL - 35

SP - 965

EP - 969

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 4

ER -